Advances in Stent Technologies (Technical Insights)


Regular Price: USD 4,950.00

Special Price USD 3,465.00

30% OFF

* Required Fields

Regular Price: USD 4,950.00

Special Price USD 3,465.00


Be the first to review this product

This research service delves with the Advances in Stent Technologies around the world.

Table of Contents

Advances in Stent Technologies (Technical Insights), Executive SummaryScope and MethodologyScope of the Research ServiceMethodologyStents--Overview and ClassificationEvolution of Drug Eluting and Bioabsorbable StentsNoteworthy Technological Innovations--A GistAdvances in Stent Technologies (Technical Insights), Technology Adoption FactorsTechnology-Related Drivers and ChallengesDrivers for the Technology and the IndustryTechnology and Industry-Related ChallengesCurrent and Future TrendsA Basic SWOT Analysis; Analyst Perceptions and InsightsDES Technology--A Basic SWOT AnalysisAnalyst Perceptions and InsightsAdvances in Stent Technologies (Technical Insights), Innovations in DES SpaceDES Innovations--USA and CanadaSuccessful Launch of Hydroxyapatite-Based Stents--CanadaCustomizable Biodegradable Stents for Single Long and Multiple Lesions--USASirolimus-Based Biodegradable Stents--USADES Innovations--Europe and Other CountriesNew Hybrid Drug Device Combination to Lower Restenosis Rates--JapanPolymer-Free Matrices to the Rescue of Interventionalists--GermanyA Stent Structure with an Unique Design and a Biostable Polymer--SpainLow-Dose Drug Release Kinetics Helps Lower Thrombosis Rates--South AfricaMelatonin-Based Drug Eluting Stents--NetherlandsLow-Dose Paclitaxel-Based Stent Scores over First Generation DES--GermanyAdvances in Stent Technologies (Technical Insights), Patent Information and Key ContactsPatents in US and EuropeUS and Canada PatentsPatents in Europe and Rest of the WorldKey Contacts and GlossaryKey Contacts--Industry and AcademiaGlossaryAdvances in Stent Technologies (Technical Insights), Decision Support DatabaseDatabase TablesTotal Healthcare Expenditure--World (2002 to 2012)Total Number of Hospitals--World (2002 to 2012)Total Number of Physicians--World (2002 to 2012)Incidence of Myocardial Infarction (Heart Attack) (2002 to 2012)Prevalence of Chronic Obstructive Pulmonary Disease (COPD) (2002 to 2012)

Related Research

Release Date : 21-Nov-18

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.